Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study
Nasal‐type extranodal natural killer NK/T‐cell lymphoma (ENKTCL) is a distinct type of non‐Hodgkin lymphoma with poor prognosis. This research aimed to evaluate the efficacy and safety of the GELOXD or P‐GEMOXD regimens in patients with ENKTCL.
No Supplementary Data
No Article Media